Maintain BUY with unchanged DCF-TP of MYR15.20 4QFY21 results met both our/consensus expectations. As Malaysia gradually emerges from the pandemic, we believe sales volume should see a similar recovery in FY22. However, new regulations would pose a fresh risk to BAT's earnings momentum in the longer-term if added restrictions are imposed on smokers below a […]

Read more of this post